De Francesch Valeria, Cazurro-Gutiérrez Ana, Timmers Elze R, Español-Martín Gemma, Ferrero-Turrión Julia, Gómez-Andrés David, Marcé-Grau Anna, Dougherty-de Miguel Lucía, González Victoria, Moreno-Galdó Antonio, Tijssen Marina A J, Pérez-Dueñas Belén
Child and Adolescent Neuropsychiatry Unit, AULSS1 Dolomiti, San Martino Hospital, Belluno, Italy.
Innovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Dev Med Child Neurol. 2025 Jun;67(6):740-749. doi: 10.1111/dmcn.16214. Epub 2024 Dec 16.
To investigate the natural progression of SGCE-associated myoclonus dystonia from symptom onset in childhood to early adulthood.
Myoclonus and dystonia were monitored using rating scales in two cohorts of participants from Spain and the Netherlands. Individual annualized rates of change were calculated and longitudinal trends were assessed using Bayesian mixed models. Psychiatric features were evaluated cross-sectionally in the Spanish cohort.
Thirty-eight patients (21 males, 17 females) were evaluated at a mean age (SD) of 10 years (4 years 7 months; range 2-21 years) and 14 years 2 months (4 years 8 months; range 4-25 years). We observed a significant worsening of action myoclonus, global dystonia, and dystonia during writing (mean annual increases of 1.356, 0.226, and 0.518 in the Unified Myoclonus, Burke-Fahn-Marsden, and Writer's Cramp Rating Scales respectively). Accordingly, participants perceived a significant worsening in their speech, writing, and walking abilities. Twenty-six of 32 participants suffered from anxiety (n = 13), obsessive-compulsive disorder (n = 9), and attention-deficit/hyperactivity disorder (n = 8).
This study demonstrates that, unlike in the adult population, myoclonus dystonia syndrome in childhood and adolescence follows a progressive course that can be debilitating in the early stages of life. These findings, along with a high prevalence of psychiatric symptoms, highlight the need for early therapeutic interventions to prevent long-term motor and psychological sequelae.
研究与SGCE相关的肌阵挛性肌张力障碍从儿童期症状出现到成年早期的自然病程。
使用评定量表对来自西班牙和荷兰的两组参与者的肌阵挛和肌张力障碍进行监测。计算个体年化变化率,并使用贝叶斯混合模型评估纵向趋势。对西班牙队列中的精神特征进行横断面评估。
38例患者(21例男性,17例女性)接受评估,平均年龄(标准差)分别为10岁(4岁7个月;范围2 - 21岁)和14岁2个月(4岁8个月;范围4 - 25岁)。我们观察到动作性肌阵挛、全身性肌张力障碍以及书写时的肌张力障碍显著恶化(在统一肌阵挛评定量表、伯克 - 法恩 - 马斯登评定量表和书写痉挛评定量表中的平均年增加量分别为1.356、0.226和0.518)。相应地,参与者感觉他们的言语、书写和行走能力显著恶化。32名参与者中有26名患有焦虑症(n = 13)、强迫症(n = 9)和注意力缺陷多动障碍(n = 8)。
本研究表明,与成人不同,儿童和青少年期的肌阵挛性肌张力障碍综合征呈进行性病程,在生命早期可能使人衰弱。这些发现以及精神症状的高患病率,凸显了早期治疗干预以预防长期运动和心理后遗症的必要性。